[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363822-105":59,"doc-detail-363822-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","trmt661a-mediated-trna-m1a-methylation-promotes-codon-dependent-tab2-translation-and-drives-aml-progression","TRMT6/61A-mediated tRNA m1A methylation promotes codon-dependent TAB2 translation and drives AML progression","","Although mRNA modifications and translational regulation have been extensively studied across cancers, the regulatory mechanisms controlling N1-methyladenosine (m1A)-modified tRNAs in acute myeloid leukemia (AML) remain unclear. This work identifies the m1A methyltransferase complex TRMT6/TRMT61A as a key oncogenic driver in leukemogenesis. TRMT6/TRMT61A is upregulated in AML, predicts poor patient outcomes, and supports leukemia cell proliferation and clonal growth via its methyltransferase activity. Mechanistically, TRMT6/TRMT61A enhances codon-frequency-dependent TAB2 translation, promoting NF-κB signaling and AML progression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/trmt661a-mediated-trna-m1a-methylation-promotes-codon-dependent-tab2-translation-and-drives-aml-progression/363822/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/trmt661a-mediated-trna-m1a-methylation-promotes-codon-dependent-tab2-translation-and-drives-aml-progression/363822.png","ImageObject",300,407,{"name":92,"@type":93},"Guten tag","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main discovery about TRMT6/TRMT61A in AML?","Question",{"text":112,"@type":113},"The TRMT6/TRMT61A complex is identified as a critical oncogenic factor in leukemogenesis, with significant upregulation in AML and association with poor prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does TRMT6/TRMT61A affect translation in the study?",{"text":117,"@type":113},"TRMT6/TRMT61A mediates m1A modification of tRNAs, increases specific tRNA subset abundance, and enhances codon-frequency-dependent translation of TAB2.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports the role of TRMT6/61A in AML progression?",{"text":121,"@type":113},"In vitro and in vivo functional assays show that TRMT6/TRMT61A is required for AML cell proliferation, clonogenic potential, and leukemogenesis, and its effect depends on methyltransferase activity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363822,1790909966,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","Jia et al. Molecular Medicine (2026) 32:104 Molecular Medicine  \n[https://doi.org/10.1186/s10020-026-01496-3](https://doi.org/10.1186/s10020-026-01496-3)  \nRESEARCH Open Access  \nTRMT6/61A-mediated tRNA m1A methylation  promotes codon-dependent TAB2 translation and drives AML progression  \nZhirong Jia1†, Xiang Wu1†, Aorong Ouyang2†, ChengZhang3, Ya Liu 1, Guocai Wu4, Zhanghui Chen1 and Songyu Li 1*  \nAbstract  \nAlthough mRNA modifications and translational regulation have been extensively studied in various cancers, the precise regulatory mechanisms governing N 1-methyladenosine (m¹A)-modified tRNAs in acute myeloid leukemia (AML) remain to be elucidated. Here, we reveal a critical oncogenic role of the m¹A methyltransferase complex TRMT6/TRMT61A in leukemogenesis. We observed that TRMT6/TRMT61A is significantly upregulated in AML and predicts a poor prognosis in patients with AML. Functional assays in vitro and in vivo showed that TRMT6/TRMT61Ais crucial for maintaining AML cell proliferation, clonogenic potential, and leukemogenesis, and that this function is dependent on its m¹A methyltransferase activity. Mechanistically, TRMT6/TRMT61A mediates m1A modification of tRNAs, thereby increasing the abundance of specific tRNA subsets and enhancing the codon-frequency-dependent translation of TAB2, a key positive regulator of the NF-κB signaling pathway. In summary, our study elucidates the oncogenic mechanism of the TRMT6/TRMT61A-tRNA m¹A-TAB2 axis in AML, providing potential strategies for targeted therapy.  \nHighlights  \n• TRMT6 and TRMT61A are upregulated in AML and are associated with poor prognosis.  \n• TRMT6/61A knockdown in AML cells inhibits proliferation and induces apoptosis.  \n• TRMT6/61A knockdown reduces tumor burden and improves survival in mouse xenograft models.  \n• TRMT6/61A regulates TAB2 expression via m1A modification, supporting leukemogenesis and disease progression.  \nKeywords AML, tRNA modification, TRMT6/TRMT61A, translation, TAB2  \n†Zhirong Jia, Xiang Wu and Aorong Ouyang contributed equally to this work.  \n*Correspondence: Songyu Li[lsyu@gdmu.edu.cn](lsyu@gdmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nJia et al. Molecular Medicine (2026) 32:104 Page 2 of 17  \nGraphical Abstract  \neTOC. Zhirong Jia et al. identified TRMT6/61A, a tRNA m1A methyltransferase, as a key regulator of AML progression. Their findings show that TRMT6/61A increases the abundance of specific tRNA subsets and enhancesTAB2 translation that is codon-frequency-dependent, promoting leukemogenesis and disease progression. Targeting the TRMT6/61Am1A axis may offer new therapeutic strategies for AML.  \nIntroduction  \nAcute myeloid leukemia (AML) is a malignant clonal disorder originating from hematopoietic stem/progenitor cells. It is characterized by abnormal proliferation ","cbCaitBrTwN7OUtn","https://ap.wps.com/l/cbCaitBrTwN7OUtn","pdf",10151581,17,"English","# Abstract\n# Highlights\n# Keywords\n# Introduction\n## AML background and treatment challenges\n## RNA modifications and epitranscriptomics\n# Graphical Abstract","[{\"question\":\"What is the main discovery about TRMT6/TRMT61A in AML?\",\"answer\":\"The TRMT6/TRMT61A complex is identified as a critical oncogenic factor in leukemogenesis, with significant upregulation in AML and association with poor prognosis.\"},{\"question\":\"How does TRMT6/TRMT61A affect translation in the study?\",\"answer\":\"TRMT6/TRMT61A mediates m1A modification of tRNAs, increases specific tRNA subset abundance, and enhances codon-frequency-dependent translation of TAB2.\"},{\"question\":\"What evidence supports the role of TRMT6/61A in AML progression?\",\"answer\":\"In vitro and in vivo functional assays show that TRMT6/TRMT61A is required for AML cell proliferation, clonogenic potential, and leukemogenesis, and its effect depends on methyltransferase activity.\"}]","TRMT6/61A-mediated tRNA m1A methylation promotes codon-dependent TAB2 translation and drives AML progression | PDF",1790153423,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b678d8ba2158df17006abb463ee9ae64.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad89e128ebd2e9886ec66071f614370d.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f7867824c403812926ef076fbdbc47f.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b42e138660f412f3d1f852e45f6af27.webp",980,1306]